IPA analysis for FGF21- PPARα/RXRα signaling in NAFLD, and NASH showed that FGF21 interacts with these genes including FASN, ADIPOQ, PPARA and PPARGC1A (Figure 1A). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.